In the 8-week Phase II trial of tirzepatide, depressive symptoms will be evaluated in patients with obesity and alcohol use disorder ( ID NCT07292519)
Some people notice a big drop in their hunger and cravings, while others may not feel as much of a change
The emergence of new, more potent, and longer-acting GLP-1RAs has spurred an interest in these treatments in BAD management
However, these new emergent dual agonists need further investigation to understand the mechanisms of action, how to interact with the respective receptors, increase efficacy, and good safety profile [90,91,92,93,94]
National Center for Health Statistics
The officer opens the cooling bag, examines the prescription label on the medication, swabs the outside of the medication pen, and tests it in a machine